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induced MPT, respiration, and phospholipid fatty acyl composition.
Both DHA and EPA enriched diets lowered circulating free fatty acids
and triglycerides byapproximately 40% (p<0.05, DHAvs CTRL and EPA
vs CTRL, NS, DHAvs EPA). DHA supplementation increasedDHAby 63%
(p<0.05 vs control) and decreased ARA by 61% (p<0.05 vs control) in
mitochondrial phospholipids, and significantly delayedMPTP opening
(57% more calcium necessary to induce MPTP vs CTRL, p<0.05). EPA
supplementation did not affect DHA, only modestly lowered ARA
(−33% vs CTRL, p<0.05), and had no effect of MPTP opening. State 3
respiration with a variety of substrates was unaffected by dietary
treatment, however DHA decreased state 4 respiration by 30% and the
increased RCR by 70% with pyruvate+malate as the substrate, both in
the absence and presence of oligomycin (p<0.05); treatmentwith EPA
had no effect. The P:O ratiowas not different among groupswith any of
the substrates. In summary, DHA supplementation favorably altered
mitochondrial phospholipid composition and delayed MPT in cardiac
mitochondria, while EPA had no effect. These effects may contribute to
the protection against heart disease with ω-3 PUFA supplementation,
and suggest that supplementationwithDHA should be superior to EPA.
doi:10.1016/j.bbabio.2010.04.243
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Nitroalkenes are electrophilic molecules which can cause post-
translational modifications of proteins and modulate their functional
activity. Previously we demonstrated endogenous formation of ni-
trated linoleate (LNO2) in mitochondria isolated from perfused heart
after ischemic preconditioning. In addition, synthetic LNO2 protected
isolated cardiomyocytes against simulated ischemia/reperfusion
injury. Biotin-tagged LNO2 replicated this cardioprotective effect,
and caused reversible modification of mitochondrial proteins. Thus,
we hypothesized that mitochondrial targets of LNO2 might play an
important role in cardioprotection. Previously we demonstrated that
LNO2 induced mitochondrial H+ leak viamodification of ANT. Further
studies revealed that LNO2 (1 µM) opened mitochondrial KATP
channels in a 5-HD and glybenclamide sensitive manner. Although
the molecular identity of the mKATP channel has not been fully
elucidated, we previously showed that complex (Cx) II might be
involved in regulation of mKATP channel activity. We found that LNO2
physically interacted with the 70 kDa subunit of Cx II and inhibited
its enzymatic activity. Notably, the cardioprotective effects of mild H+
leak, opening of mKATP channels and reversible inhibition of the respi-
ratory chain are well documented. Thus, our findings characterize
LNO2 as a pleotropic molecule which might recruit several protective
mitochondrial pathways to elicit cardioprotection.
doi:10.1016/j.bbabio.2010.04.244
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Nowadays, Doxorubicin (DOX) is probably one of the most effec-
tive anticancer drugs available in the clinic. However, the treatment
is usually followed by a cumulative and persistent cardiotoxicity.
Mitochondria have a critical role in DOX-mediated toxicity however
there are still doubts whereas mitochondrial toxicity is specific to the
heart. Therefore, the present work characterizes two differentmodels of
toxicity (acute vs. sub-chronic), regarding mitochondrial physiology
from three different tissues (heart, liver and kidney) from treated rats.
Wistar rats were sub-chronically (7 wks, 2 mg/kg) or acutely (20 mg/
kg) treated with DOX and allowed to rest oneweek or 24 h after the last
injection, respectively. Sub-chronically-treated animals showed a de-
crease in body mass gain during treatment while no changes were
observed in acute model. Plasma profile from both models was altered
but the sub-chronic treatment presented the most dramatic changes.
Histological analysis revealed the presence of lipid droplets in liver slices
from acutely treated rats. Regarding mitochondrial bioenergetics,
differences between saline and DOX-treated rats were observed: in the
acute model, differences included state 3 respiration in the liver and
kidneyand theADP/O in theheart. In the sub-chronicmodel, differences
regarding state 3 respiration in the heart and kidney was observed. We
also determined that cardiac mitochondria from sub-chronic-treated
animals presented a lower calcium loading capacity, which was not
observed in the other tissues. However, gene expression analyses
showed no alterations in the chronic model but interestingly, decreased
mRNA levels for the ANT, VDAC and increased CyP-D mRNA were
detected in the acute model. Aconitase activity, a sensitive marker of
oxidative stress, was decreased in the kidney (acute model) and in the
heart (sub-chronic model). In conclusion, data confirm that mitochon-
drial alterations result from DOX treatment, being more severe in the
heart and are very dependent on the treatment protocol. It remains to be
determined if mitochondrial alterations in organs such as liver and
kidneys are a specific and direct effect of DOX onmitochondria or if they
result of secondary effects of DOX on other targets.
The present work is supported by the Portuguese FCT (SFRH/BD/
36938/2007 to GP, PTDC/SAU-OSM/64084/2006 and PTDC/SAU-
OSM/104731/2008 to PO).
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Glycine, inhibitory neurotransmitter, has been found to be effective
against neuronal cell death in in vivo and in vitro models of ischemic
stroke. We have shown that glycine prevented respiratory index
depletion of mitochondria in the homogenate of the cerebral cortex after
24 h common carotid artery occlusion in rats, along with preventing the
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activation of caspase 3. Glycine also maintained phosphorylating ability
of mitochondria after incubation of rats' brain cortex slices under anoxia
for 30 min. Neuronal death during ischemic stroke mediated by
glutamate excitotoxicity which results in elevation of intracellular
calcium concentration. Elevated concentrations of calcium inducemito-
chondrial permeability transition pore, which dissipates mitochondrial
electrochemical gradient and lead to energy collapse. Therefore we
investigated theeffectof glycine to influencedirectly on calciumcapacity
of isolated mitochondria in conditions close to brain tissue surviving
during ischemic stroke.We studied the calciumcapacity of isolated brain
mitochondria after incubation under anoxia at different temperatures
and the effect of glycine on this parameter. Concentration of calcium in
the incubation medium and the mitochondrial membrane potential
were measured. Incubation of the mitochondria at room temperature
(22 °C) under 30 min of anoxia led to a decrease of the calcium capacity
of mitochondria by 80–90% compared with intact mitochondria, also
significantly decreased sensitivity to cyclosporin A. Calcium capacity at
the same conditions and in the presence of glycine 5 mM was reduced
only by 50–60%. Therewas a concentrationdependence of this effect and
it could be observed under not less than 2 mM glycine. Our data show
that glycine prevents decrease of calcium capacity in isolated brain
mitochondria during anoxic conditions. These findings suggest a novel
mechanism for glycine as a potential stroke therapeutic.
doi:10.1016/j.bbabio.2010.04.246
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Over the world, brain ischemia is one of the most common causes of
death and adult disability. Oxidative stress is known to be highly
associated with brain ischemia with an important role of mitochondria
as a major source of reactive oxygen species. Therefore, therapeutic
approaches targeting mitochondrial dysfunction and oxidative damage
holdgreatpromise inneurodegenerativediseases.Wetestedmitochondria-
targeted chimeric compounds carrying antioxidant moiety as potential
agents to efficiently alleviate the deleterious consequences of ischemic
insult. Amongall tested compounds the highest efficiencywasdisplayed
by SkQR1 consisting of a rhodamine moiety linked to a plastoquinone
residue. Brain ischemia in rats was induced by insertion of a silicon-
coated thread in the middle cerebral artery (MCA). The volume of brain
infarct was determined on the first postoperative day by magnetic
resonance imaging. Behavioral test was performed 1 day before the
surgery and on the first day after the induction of ischemia. Measuring
the proteins content in the brain homogenate tissuewas determined by
Western blotting. We found that a single intraperitoneal injection of
SkQR1 at the concentration of 0.5, 1, 2 mM/kg before and after MCA
occlusion significantly diminishes infarct volume and improves perfor-
mance of a test characterizingneurological deficit of ischemic animals in
a dose-dependent manner. An analog of SkQR1 without plastoquinone
did not display apparent neuroprotective properties. We also revealed
that SkQR1 activates signaling pathways involved in ischemic tolerance
induction.We conclude that beneficial effect of rhodamine derivative of
mitochondria-targeted compound SkQR1 causing significant improve-
ment of neurological functions and decreased infarct volume may be
explained by a direct antioxidative effect of the drug. However, we
cannot exclude some other mechanisms of SkQR1 action, in particular,
through a mechanism of ischemic tolerance induction.
doi:10.1016/j.bbabio.2010.04.247
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Isoforms of creatine kinase (CK) are key players in energy
metabolism ofmany cells with high and/or fluctuating energy demands
byprovidingenergybuffer and energy transfer functions. Theyare easily
inactivated in situations of oxidative stress, whichmakes them a critical
factor for energy failure occurring in many related pathologies. Reactive
oxygen and nitrogen species (ROS, RNS) not only induce enzymatic
inactivation, which occurs with all CK isoenzymes, but also specific
damage to the mitochondrial CK isoforms (MtCKs). This includes
impairment of critical MtCK properties like destabilization of the native
octameric state or decreased membrane binding capacity [1]. Using
purified recombinant proteins, cell homogenates and mitochondria
isolated from rat heart and brain, we have compared sarcomeric sMtCK
(expressed in heart and skeletal muscle) and ubiquitous uMtCK
(expressed in many other tissues) with respect to their sensitivity to
oxidative inactivation induced by the drug doxorubicin or occurring
spontaneously after extraction under non-reducing condition. Sarco-
meric sMtCK showed significantly higher sensitivity to oxidation and
was the isoform responsible for the loss of CK activity in heart extracts
upon storage under non-reducing conditions. The sMtCK dimer was
more easily inactivated as compared to the octamer, and solubilization
of sMtCK from membrane (promoting dimerization) made the protein
an especially vulnerable substrate for inactivation. This differential
susceptibility of the two MtCK isoenzymes has been related to some
differences in their molecular structures (e.g. number and surface
exposure of cysteine residues). It may contribute to energy deficits that
occur in oxidatively stressed heart expressing the sMtCK isoform [2,3].
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